Histological Study Of Liver And Intestine Of Rats Treated With Colchicine by Azza Abd El Maguid.
The Egyptian Journal of Hospital Medicine Vol., 23: 277– 286                             June  2006         
                                                                                                                              I.S.S.N: 12084 
1687       –    2002      
 
Histological Study Of Liver And Intestine Of Rats Treated With Colchicine 
 
Azza Abd El Maguid. 
Health Radiation Research Department, National Centre for Radiation 
Research and Technology, Cairo, Egypt. 
 
Abstract  
 
         The aim  of  the  present  work is  to  detect  the  effect of  colchicine  administration  on  the 
histology of the liver and intestine in albino rats. 
         Most drugs have side effects which represent a great problem for human. Some of these 
side effects may be serious. An example of these drugs is colchicine. Its only approved use is to 
treat gout, though it is also occasionally used in veterinary medicine to treat cancers in some 
animals.  It  is  also  used  as  an  antimitotic  agent  in  cancer  research  involving  cell  cultures. 
Colchicine  was  given  i.p  with  a  dose  of  3mg/kg  body  weight  daily  for  a  period  of  5  days. 
Histological examinations were carried out at one, four and seven days post treatment.  
         Histological examination of liver one, four and seven days post treatment with colchicine 
showed  sporadic  necrosis,  loss  of  hepatic  architecture,  pyknosis  and  vacuolations  of  some 
hepatocytes, corrugated hepatic portal vein surrounded by large fibrotic area, edema of portal 
tract  with  new  bile  ductules  formation,  dilatation  and  congestion  of  hepatic  sinusoids, 
multihaemorrhagic  areas,  hypertrophied  hepatocytes  with  deeply  stained  shrunken  nuclei  and 
mononuclear cells infiltration replacing focal areas of hepatic necrosis.  
         Histological  examination  of  intestine  showed  no  changes  one  day  post  treatment  with 
colchicine.  At  four  and  seven  days  post  treatment,  the  intestine  revealed  hyperplasia  and 
hyperactivation  of  mucous  secreting  cells  and  intestinal  glands  and  mononuclear  cells 
infiltration and edema in lamina propria with multihemorrhagic areas. 
In  conclusion,  the  present  study  has  shown  that  colchicine  has  a  toxic  effect  and  some 
histopathological  changes  have  been  detected,  so  care  should  be  taken  when  colchicine  is 
prescribed in gout treatment.  
 
Introduction 
   
         The autumn Crocus has been known 
since  the  times  of  ancient  Greece.  In  the 
fifth century, herbalists discovered it and it 
could be used to treat rheumatism, arthritis 
and gout. The useful active ingredient in the 
plant  is  called  colchicine.  It  is  one  of  the 
oldest  drugs  which  were  used  in  the 
treatment of  gout and  is  still useful  in  the 
treatment  of  several  other  diseases 
(Bertram, 1992 and Eric et al., 1992) and 
was  used  by  physicians  for  the  last  150 
years.  
         Colchicine is a water-soluble alkaloid 
and it is found in the autumn crocus. It has 
the ability to block or suppress cell division 
by  inhibiting  mitosis.  Specifically,  it 
inhibits the development of spindles as  the 
nuclei  are  dividing.  Normally,  the  cell 
would  use  its  spindle  fibers  to  line  up  its 
chromosomes,  make  a  copy  of  them,  and 
divide  into  new  cells  with  each  daughter 
cell  having  a  single  set  of  chromosomes. 
Colchicine  blocks  formation  of  spindle 
fibers  and  so  the  cell  can’t  move  its 
chromosomes around. The cell may end up 
copying  some  or  all  of  the  chromosomes 
anyway, but can’t parcel them out into new 
cells,  and  so  it  never  divides.  It  has  been 
proposed  as  a  novel  drug  for  therapy  of 
pulmonary  fibrosis  (Entzian  et  al.,  1997). 
Borisy  and  Taylor  (1967)  reported  that 
colchicine  is  one  of  the  micro  tubule-
disruptive agents and it binds with tubulin, 
which  is  the  microtubule-protein.   
Colchicine was also reported by Ostermann 
et  al.  (1993)  and  Perico  et  al.  (1996)  to 
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inhibit cell-mediated immune responses and 
promotes  long-term  survival  of  major 
histocompatability  complex-incompatabile 
renal allografts in rat. 
         Because  cancer  cells  divide  much 
more rapidly than normal cells, cancers are 
more  susceptible  to  being  poisoned  by 
mitotic  inhibitors  such  as  colchicine, 
paclitaxel, and the Vinca alkaloids.  
  Gout is a disease caused by faulty 
uric  acid  metabolism  in  which  excess  uric 
acid is turned into crystals of sodium urate, 
which are then deposited in the joints (most 
often in the big toe), causing inflammation 
and  pain.  Researchers  aren't  sure  exactly 
how  colchicine  works  against  gout,  but  it 
seems  to  reduce  the  frequency  of  severe 
attacks  and  relieves  residual  pain. 
Colchicine  is  unique  among  therapeutic 
agents  used  in  the  treatment  of  acute 
arthritis.  Its  usefulness  is  generally  felt  to 
be  relatively  limited  to  this  rheumatic 
disease  and  that  it  is  not  a  potent  general 
anti-inflammatory agent (Malawista, 1975). 
         Colchicine  is  rapidly  absorbed  from 
the  gastrointestinal  tract
 after  ingestion.  It 
undergoes significant first pass hepatic
 met-
abolism, which  primarily involves  deacety-
lation.  It  is  thought  that
 the  extended  time 
period  during  which  the  gastrointestinal 
mucosal
 cells are exposed to colchicine may 
explain  the  prominence  of
 the  gastrointe-
stinal  symptoms  of  toxicity.  Subsequent
 to 
this,  the  metabolites  undergo  widespread 
enterohepatic  recirculation
  before  being 
excreted  in  bile  and  faeces  (Borron  et  al., 
1996). 
         As  far  as  side  effects  go,  colchicine 
caused a temporary reduction in the number 
of  leukocytes  (white  blood  cells)  in  the 
blood  stream;  afterward,  the  leukocyte 
count  can  rebound  to  abnormally  high 
levels.  Colchicine  also  caused  teratogenic 
birth defects in lab animals and injection of 
colchicine  in  pregnant  mice  resulted  in 
cytolytic  effects  on  fetal  hepatocytes  and 
macrophages (Sonada et al., 1998), and so 
pregnant  women  with  gout  should  not  use 
colchicine-containing drugs. 
         Colchicine  poisoning  resembles 
arsenic poisoning  because  of  its  poisonous 
effect  on  mitosis  and  occurs  2  to  5  hours 
after  the  toxic  dose  which  has  been 
ingested,  the  symptoms  include  burning  in 
the  mouth  and  throat,  diarrhea,  stomach 
pain,  vomiting,  and  kidney  failure.  A 
specific antidote doesn't exist, so treatment 
typically  involves  giving  the  victim 
activated charcoal or pumping the stomach 
to decrease absorption if it was orally taken 
(Wagenaar, 2004).   
         This study was designed to investigate 
the effect of  colchicine on  the structure  of 
liver  and  intestine  of  rat  trying  to  give 
warnings  about  using  this  drug  in  gout 
patients.   
 
Material and Methods 
 
Animals 
  Male  Swiss  albino  rats  (120-140) 
were  used.  The  animals  were  housed  in 
specially  designed  cages  and  were  kept  in 
controlled room in the animal house facility 
of National  Centre  for  Radiation  Research 
and Technology (NCRRT) at a  maintained 
good temperature and humidity. They were 
given  standard  food  and  normal  tap  water 
daily.  
 
Colchicine treatment 
  Colchicine  (Sigma)  was  given  as 
intra  peritoneal  injections  with  a  dose  of 
3mg/kg/day  for  5  days  (double  the 
therapeutic dose).  
 
Experimental design 
  The animals were divided into four 
groups of  4 each  according  to the  time  of 
sampling:  (Group  1):  control  group,  the 
animals  received  i.p.  injection  of  saline. 
(Group 2):  The  animals  were  sacrificed  at 
one  day  post  treatment  with  colchicine. 
(Group 3):  The  animals  were  sacrificed  at 
four  days  post  treatment  with  colchicine. 
(Group 4):  The  animals  were  sacrificed  at 
seven days post treatment with colchicine. 
 
Histological analysis 
         Rats of each group were sacrificed at 
1,  4  and  7  days  after  treatment  with 
colchicine.  Animals  were  sacrificed  by 
decapitation,  the  liver  and  the  intestine, 
were  excised  and  fixed  in  10%  formalin, 
dehydrated  in  ascending  grades  of  ethyl 
alcohol,  cleared  in  xylol,  embedded  in Azza Abd El Maguid. 
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molten paraplast at 56°C and cut at 5µ on 
rotator  microtome.  The  paraffin  sections 
were  stained  with  haematoxylin  and  eosin 
(Drury  and  Wallington,  1980).  Histop-
athological  studies  were  undertaken 
through  light  microscopy  and  photomicr-
ographs were made. 
 
Results 
 
Liver Examination   
  Liver sections of control, untreated 
rat revealed normal histological structure of 
hepatic lobules (Fig. 1).              
         Liver  section  of  a  rat  treated  with 
colchicine  one  day  post  treatment  showed 
sporadic  necrosis  of  hepatocytes  (Fig.  2), 
focal area  of  hepatic  necrosis  occupied  by 
leucocytic cells infiltration (Fig. 3) as well 
as edema in the  portal tract with new  bile 
ductules formation (Fig. 4). 
         Liver of a rat treated with colchicine 
after  four  days  revealed  dilatation  and 
congestion of hepatic sinusoids with lots of 
hemorrhagic  areas  (Fig.  5),  vacuolation  in 
some  hepatocytes,  and  loss  of  hepatic 
architecture  with  increased  signs  of 
necrosis,  dilated  sinusoidal  spaces  and 
multi  hemorrhagic  areas  (Fig.  6).  A  large 
degenerated  area  which  is  occupied  by 
hemorrhage  was  detected.  Some 
hepatocytes  were  free  from  nuclei  and 
others contained pyknotic nuclei (Fig. 7). 
         At  seven  days  post  treatment  with 
colchicine  the  liver  showed  hypertrophied 
hepatocytes  with  deeply  stained  shrunken 
nuclei  and  small  necrotic  area  (Fig.  8). 
Focal area  of hepatic  necrosis replaced  by 
mononuclear leucocytic cells (Fig. 9), large 
haemorrhagic areas with increased signs of 
necrosis  and  disturbed  architecture  of 
hepatic tissue (Fig.10), edema in the portal 
tract  associated  with  new  bile  ductules 
formation,  corrugated  portal  vein  surrou-
nded  by  a  fibrotic  area  and  the  adjacent 
hepatocytes  were  highly  affected  with 
foamy appearance (Fig. 11). 
         Intestine  of  control,  untreated  rat 
revealed no histopathological changes (Fig. 
12). No changes were detected in examined 
sections of rat treated with colchicine at one 
day post treatment (Fig. 13). 
         At  four  days  post  treatment  with 
colchicine  the  intestine  revealed  activation 
of mucous  secreting epithelium  and  glands 
with hemorrhagic area (Fig. 14). 
         Hyperplasia  and  hyperactivation  of 
mucous  secreting  cells,  mononuclear  cells 
infiltration  and  edema  in  lamina  propria 
with  large  degenerative  areas  containing 
cellular debris and small hemorrhagic areas 
were observed in examined intestine treated 
with  colchicine  seven  days  post-treatment 
(Fig. 15). 
 
 
 
 
 
 
 
 
 
Fig. 1: Liver of control, untreated rat showing 
normal architecture of liver tissue, normal hepatic 
strands  (1) and central vein (2).  (Hx & E stain X 
200).   
1  
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Fig.2:  Liver  of  a  rat  one  day  post-treatment  with 
colchicine showing sporadic necrosis of hepatocytes (↑). 
(Hx & E stain X 200). 
Fig.  3:  Liver  of  a  rat  one  day  post-treatment  with 
colchicine  showing  focal  area  of  hepatic  necrosis 
occupied  by  leucocytic  cells  infiltration  (↑).  (Hx  &  E 
stain X 200). 
Fig.  4:  Liver  of  a  rat  one  day  post-treatment  with 
colchicine showing edema in the portal tract (↑) and new 
bile ductules formation (▲). (Hx & E stain X 200). Azza Abd El Maguid. 
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Fig. 8: Liver of a rat treated with colchicine seven days 
post treatment showing hypertrophied hepatocytes with 
deeply stained shrunken nuclei (↑) and small necrotic 
area with dark pyknotic nuclei (▲). (Hx & E stain X 
200). 
Fig. 6: Liver of rat treated with colchicine four days post-
treatment showing vacuolation of some hepatocytes (↑), 
loss of hepatic architecture with increased signs of necrosis 
and dilated sinusoidal areas (▲) and multihemorrhagic 
areas (h). (Hx & E stain X 200) 
h  
h  
Fig. 7: Liver of rat treated with colchicine four days post 
treatment  showing  large  degenerated  area  which  is 
occupied  by  hemorrhage  (↑).  Some  hepatocytes  were 
free  from  nuclei  and  others  contained  pyknotic nuclei 
(▲). (Hx & E stain X 200) 
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Fig. 13: Intestine of rat treated with colchicine one day post 
treatment, no histopathological changes were detected. (Hx 
& E stain X 200). 
Fig. 9: Liver of a rat treated with colchicine seven days 
post treatment showing focal area of hepatic necrosis 
replaced by mononuclear cells (↑). (Hx & E stain X 
200). 
Fig. 12: Intestine of control, untreated rat showing normal 
histological pattern. (Hx & E stain X 100). 
Fig. 11: Liver of a rat treated with colchicine seven days 
post  treatment  showing  edema  in  the  portal  tract  (↑) 
associated  with  new  bile  ductules  formation  (▲)  and 
corrugated portal vein surrounded by fibrotic area (v). 
(Hx & E stain X 200). 
v  
Fig. 10: Liver of a rat treated with colchicine seven days 
post treatment showing large haemorrhagic area (↑) & 
disturbed  architecture  of  hepatic  tissue  with  increased 
signs of necrosis (▲) (Hx & E stain X 200). Azza Abd El Maguid. 
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Discussion 
            
         Colchicine overdose is uncommon but 
potentially  life  threatening.
 Colchicine  is  a 
safe  drug  when  used  according  to  establ-
ished  therapeutic
  guidelines  but  causes 
serious systemic effects if ingested in
 doses 
that exceed the recommendations. 
         In  the  present  study,  histological 
parameters  were  followed  in  the  liver  and 
intestine of albino rats treated with colchi-
cine to detect its effects on different tissues. 
         The  administration  of  colchicine 
resulted in histopathological changes in the 
liver of rat manifested by sporadic necrosis, 
pyknosis  and  vacuolations  of  some 
hepatocytes,  leucocytic  cells  infiltration, 
and  edema  of  portal  tract  with  new  bile 
ductules, corrugated portal vein surrounded 
by  fibrotic  area,  hepatocytes  with  foamy 
appearance,    dilatation  and  congestion  of 
hepatic  sinusoids,  hepatic  haemorrhage, 
loss  of  hepatic  architecture  and 
mononuclear  cells  infiltration  replacing 
focal  areas  of  hepatic  necrosis.  These 
findings  run  in  full  agreement  with  the 
results of other  authors (El-Shafeey et  al., 
2000 and Bumbasirevie et al., 1996).  
         Das et al. (2000) studied the antiox-
idant  and  antifibrotic  properties  of  colchi-
cine. They summarized that colchicine  had 
only  weak  antioxidant  properties,  but 
afforded  some  protection  against  oxidative 
stress;  more  importantly,  long  treatment 
with this drug may be of value in producing 
regression of established cirrhosis.   Baum-
gartner et al. (2001) reported that colchicine 
inhibits  taurodeoxychlate  transport  in 
pericentral but not in periportal hepatocytes  
         Also  colchicine  administration  revea-
led hyperplasia and hyperactivation of muc-
ous  secreting  epithelium  and  glands  and 
mononuclear cells infiltration and edema in 
lamina  propria  with  large  degenerative 
areas  containing  cellular  debris  and  small 
multihemorrhagic  areas  in  examined 
intestine of  rat.  This may  be  explained  by 
Hampton  (1966)  who  stated  that  the 
intestinal  pathology  after  large  doses  of 
colchicine  is  probably  related  to  cessation 
of  cellular  proliferation  and  has  been 
compared  to  that  observed  in  acute 
radiation injury of the bowl. Also Hawkins 
et  al.  (1965)  and  Finger  and  Headington 
(1963)  reported  that  it  has  been  generally 
assumed  that  gastroenterologic  symptmat-
ology and pathology encountered with large 
doses of colchicine  are probably the  result 
of inhibition of growth of cellular elements 
of crypts. Karmeli et al. (1997) stated that 
Fig. 15: Intestine of rat treated with colchicine seven days 
post treatment showing hyperplasia and activation of mucous 
cells (↑), mononuclear cells infiltration and edema in lamina 
propria with large degenerative areas containing  cellular 
debris  (▲) and multi small hemorrhagic areas (h). (Hx & E 
stain X 200).  
Fig. 14: Intestine of rat treated with colchicine four days post 
treatment showing activation of mucous secreting epithelium 
and glands (↑) with hemorrhagic area (h). (Hx & E stain X 
200).  
h  
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colchicine induced a significant decrease in 
jejunal nitric oxide synthase activity (NOS) 
and  suggested  that  the  effect  of  colchicine 
on  intestinal  transport  is,  at  least  partly, 
mediated through  nitric oxide  (NO)  inhibi-
tion. Colchicine is well known to be associ-
ated  with  malabsorption  and  it  has  been 
shown  that  this  drug,  when  given  in  large 
doses, can cause an almost complete loss of 
intestinal villi, with concomitant steatorrhea 
and  xylose  malabsorption,  as  well  as  a 
depression  in  activity  of  disaccharides  in 
the intestine of man (Race et al., 1966).  
         Previous  studies  were  made  on 
colchicine  toxicity  and  poisoning  due  to 
over doses or accidental ingestion. Yamada 
et al. (1998) made a histopathological study 
of experimental acute poisoning of cattle by 
autumn  crocus  (Colchicum  autumnale  L.). 
They reported that all the calves developed 
severe  diarrhea  and  died  or  euthanized 
within  63  hr.  and  at  necropsy  the  gastro-
intestinal  mucosa  was  edematous  and 
hemorrhagic  and  histologically,  necrosis 
and  degeneration  with  karyopyknosis  and 
karyorrhexis  were  shown  in  the  basal  cell 
layer  of  the  tongue,  esoghagus,  forestom-
ach, renal pelvis, urinary bladder, neck cell 
layer  of  the  abomasal  gastric  glands  and 
intestinal crypts. They also reported that the 
lesions  of  the  present  acute  crocus 
poisoning of cattle closely resembled  those 
reported  in  humans  with  colchicine 
intoxication. 
         Colchicine  is  rapidly  absorbed  from 
the  gastrointestinal  tract
 after  ingestion.  It 
undergoes significant first pass hepatic
 met-
abolism, which  primarily involves  deacety-
lation.  Subsequent
 to  this,  the  metabolites 
undergo  widespread  enterohepatic  recircul-
ation
  before  being  excreted  in  bile  and 
faeces. It is thought that
 the extended  time 
period  during  which  the  gastrointestinal 
mucosal
 cells are exposed to colchicine may 
explain  the  prominence  of
  the 
gastrointestinal  symptoms  of  toxicity 
(Maxwell et al., 2001).  
         Currently  there  is  no  specific 
treatment  commercially  available  for  the 
treatment  of  colchicine  toxicity.  However, 
the  successful  outcome  after  the  use  of 
colchicine specific Fab fragments has been 
reported (Scherrmann et al.1992 and Milne 
and  Meek.,  1998).  Colchicine  specific
 Fab 
fragments  consist  of  the  light  chain  and 
variable region
 of  the  heavy  chain  and  are 
derived  from  goats  (Kaplan  et  al.,1986). 
Their mechanism
 of action is similar to that 
of  digoxin  specific  Fab  fragments,
 namely 
binding  to  the  target  drug  allows  redistri-
bution  into
  the  intravascular  compartment 
and thus the removal of substantial
 amounts 
from  peripheral  sites  (Schaumann  et  al. 
1986).There  is  a  high  affinity  between
 the 
Fab fragment and colchicine and this acts to 
prevent  the
  drug  returning  to  these 
peripheral binding sites (Baud et al. 1995). 
         Klintschar  et  al.  (1999)  examined  a 
case  in  which  two  persons  confused  this 
highly  poisonous  plant  with  wild  garlic 
(Allium  ursinum),  a  popular  spice  in  the 
central European cuisine. While one person 
merely  complained  about  a  3-day  episode 
of  nausea,  vomiting  and  watery  diarrhea, 
the  second  person  died  of  multi-organ 
system  derangements  48  h  after  the 
ingestion of the colchicum leaves. At auto-
psy hemorrhagic lung oedema, hypocellular 
bonemarrow, centrilobular fatty necrosis of 
the  liver  and  necrosis  of  the  proximal 
convoluted  tubules  of  the  kidneys  were 
observed.  
         In conclusion, it is important therefore 
that  the  potential  dangers  of  this  drug  are 
recognized by clinicians on its prescription, 
and  that  patients  are  given  an  underst-
andable explanation of its effects including 
the  point  at  which  to  cease  ingestion.  A 
careful watch must be made of the number 
of tablets prescribed to avoid unintentional 
overdose of this potentially lethal drug. 
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 تيجولوتسه تسارد  ىف هيسشلوكلاب تلماعملا ناذرجلا ءاعمأ و دبك  
 
باهولا دبع ديجملا دبع ةزع  
تيػاؼشلإا تيحصلا دىحبلا مسق  
عاؼشلإا ايصىلىنكح و دىحبل ًمىقلا ضكشملا -   ةشهاقلا -   شصم  
 
 
           السنسل ت كلكم  لزمح كلزب تيبناص سارآ اهل شيقاقؼلا مظؼم  .  زله  لم ذلداو  يلسكلىكلا  
طشقنلا ضشم سلاػ ًف مذخخسح ًخلاو شيقاقؼلا .  
           اهساذقم تػشضب  قحلا قيشغ  ػ  ارشض ل  يسكلىكلا ًطػأ ذقلو 3 مضم /   اليمىي ملضك
 ةذمل 5   مايأ  .  ًغالؼح  لم ماليأ تؼبلس و ماليأ تلؼبسأ و مىلي ذؼب تيصىلىخسهلا ثاساسذلا جيشصأو
 يسكلىكلا .  
بسح ذق  يكسلىكلا  أ شئاخنلا ثشهظأ ذق و  ذلبكلا ًلف تيضيلسنلا ثاشليرخلا طلؼب دوذلد ًف ب
 تلليىناا  لل حح شهاللظم غللم مصلابىخيللسلا ملاحمللظا و سىمللظ ًللف تلل زمخم ثاللؼماا ًللف كلزلكو
 ثالعيبلا تليباهخللإا ايلاخلا طؼب سىهظ و فيضن و تيذبكلا ايلاخلا طؼب ًف ثاغاشف دىصوو
إ غللم ةاىللنلا تلليدادأ الليلاخلا سىللهظو تلليىمذلا وىلليضلا ًللف عاللسحإ و  مذلللا ثالليشك دذللػ دالليدص
يذبكلا شيسنلا ًف ثاعيبلا .  
           ًغاللؼخل تللضيخن تيضيللسنلا ثاشلليرخلا طللؼب  اللعيأ الليف ثشللهظ ذللقف ثاللؼماا شيللسن اللمأ
 مذللا ثاليشك دذلػ ةداليصو تليغاخملا دذلرلا ًلف غاكنو ايلاخلا ًف ةدايص ًف ت زمخم  يكسلىكلا
 ًف طاكحسإو ةاىنلا تيدادأ ايلاخلا ثاعيبلا  شيسن ثاؼملاا .  
 ذنػ سزحلا بضي ازهلو ةساعلا تيبناضلا سارلآلا طؼب ال  يسكلىكلا ساقػ  أ ذحبلا ازه مذيو
الامؼخسإ .  
 
  
 
 